Detalles de la búsqueda
1.
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.
Mult Scler
; 27(3): 475-478, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32538681
2.
Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
Br J Clin Pharmacol
; 80(4): 727-39, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25808588
3.
Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.
Pharmacoepidemiol Drug Saf
; 24(4): 353-60, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25644395
4.
Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.
Antimicrob Agents Chemother
; 58(8): 4392-8, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24841264
5.
No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
Rheumatology (Oxford)
; 53(4): 757-63, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24369411
6.
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.
BMJ Open
; 14(4): e083550, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38663923
7.
Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study.
J Clin Psychopharmacol
; 33(4): 453-62, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23764684
8.
Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.
Br J Clin Pharmacol
; 75(3): 822-30, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22816796
9.
Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.
Am J Med Genet A
; 158A(3): 588-96, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22319001
10.
Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).
Basic Clin Pharmacol Toxicol
; 128(4): 579-582, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33275828
11.
Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
Arch Gynecol Obstet
; 281(2): 221-7, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19444462
12.
Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.
J Hypertens
; 38(2): 354-361, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31584512
13.
Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study.
J Hypertens
; 38(1): 133-141, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31568057
14.
Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Br J Clin Pharmacol
; 66(5): 695-705, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18754846
15.
The safety of cetirizine during pregnancy. A prospective observational cohort study.
Reprod Toxicol
; 26(1): 19-23, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18571373
16.
Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
Reprod Toxicol
; 26(1): 36-41, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18588969
17.
The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Reprod Toxicol
; 26(1): 24-30, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18585452
18.
Methotrexate in pregnancy: still many unanswered questions.
RMD Open
; 9(1)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921981
19.
Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study.
Reprod Toxicol
; 81: 79-83, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30017588
20.
Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort study.
Pregnancy Hypertens
; 13: 65-71, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30177074